Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 2412 questions Show Answers
To ask the Scottish Government what its position is on whether the recording of biological sex by public bodies is necessary for (a) accurate crime statistics and (b) public transparency.
To ask the Scottish Government what guidance it has issued to Police Scotland on the recording of sex and gender in criminal justice processes.
To ask the Scottish Government what analysis it has undertaken of any impact of NHS pay increases on recruitment and retention in the adult social care sector.
To ask the Scottish Government what its position is on the degree to which achieving net zero is a moral imperative, in light of reports that doing so will have a disproportionate impact on Scottish industries.
To ask the Scottish Government what its position is on Police Scotland’s reported policy of not automatically recording the biological sex of rape or sexual assault suspects.
To ask the Scottish Government what progress it has made on its pledge to eliminate delayed discharge from hospitals.
To ask the Scottish Government what steps it is taking to ensure there is equitable access to givinostat across all NHS boards while the Scottish Medicines Consortium reviews the drug.
To ask the Scottish Government whether it will provide additional funding or support to NHS boards to help administer early access programmes for (a) givinostat and (b) other treatments for rare diseases.
To ask the Scottish Government what data it has on the number of diversion from prosecution decisions made in relation to violent youth offenders in each of the last five years.
To ask the Scottish Government what discussions it has had with NHS boards regarding the implementation of early access to givinostat for eligible patients with Duchenne muscular dystrophy.